15 MRT-3 depot personnel infected with coronavirus | Inquirer

15 MRT-3 depot personnel infected with coronavirus

11:56 AM June 18, 2020

GCQ MRT-3 1

Niño Jesus Orbeta/Philippine Daily Inquirer

MANILA, PHILIPPINES – Fifteen workers at the Metro Rail Transit-3 (MRT-3) depot have tested positive for the coronavirus disease 2019 (COVID-19), based on swab test results, the Department of Transportation (DOTr) said on Thursday.

In a statement, the DOTr said one depot worker initially tested positive for COVID-19 on June 14. After conducting contact tracing, DOTr identified 32 personnel who interacted with the infected depot worker.

Article continues after this advertisement

All 32 workers then underwent reverse transcription polymerase chain reaction (RT-PCR) test, with 14 testing positive for the novel coronavirus that caused COVID-19.

FEATURED STORIES

The 15 infected workers are employed by Sumitomo-Mitsubishi Heavy Industries-(MHI)-TES Philippines-(TESP), the current service provider of the MRT-3.

Hence, all MRT-3 and Sumitomo-MHI-TESP personnel will undergo rapid testing which will be conducted by the Philippine Coast Guard (PCG) as a precautionary measure against COVID-19.

Article continues after this advertisement

MRT-3 director Michael Capati vowed to continue implementing health measures to suppress the spread of COVID-19 in the workplace.

“The health and safety of our employees and passengers are primordial to us. All employees will be required to undergo testing. We have been conducting disinfection in the depot, at stations, and in trains,” Capati said. (Jim Mendoza, Trainee)

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

EDITORS' PICK
MOST READ
globalnation
lifestyle
entertainment
entertainment
sports
sports
www
business
www
globalnation
sports
TAGS: coronavirus Philippines, Metro, MRT 3, Personnel

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.